{"id":"NCT01340937","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)","officialTitle":"A Phase III Randomized, Partially Double-Blind, Active-Comparator-Controlled, Lot-to-Lot Consistency Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 6 Months Concomitantly With Prevnar 13™ and RotaTeq ™","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05-10","primaryCompletion":"2012-12-18","completion":"2013-07-26","firstPosted":"2011-04-25","resultsPosted":"2016-05-02","lastUpdate":"2018-11-15"},"enrollment":2808,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Bacterial Infections","Virus Diseases"],"interventions":[{"type":"BIOLOGICAL","name":"V419","otherNames":[]},{"type":"BIOLOGICAL","name":"PENTACEL™","otherNames":[]},{"type":"BIOLOGICAL","name":"Prevnar 13™","otherNames":[]},{"type":"BIOLOGICAL","name":"RotaTeq™","otherNames":[]},{"type":"BIOLOGICAL","name":"Recombivax HB vaccine","otherNames":[]}],"arms":[{"label":"V419 Lot A","type":"EXPERIMENTAL"},{"label":"V419 Lot B","type":"EXPERIMENTAL"},{"label":"V419 Lot C","type":"EXPERIMENTAL"},{"label":"Control","type":"ACTIVE_COMPARATOR"}],"summary":"This study will determine whether three manufacturing lots of V419 (PR5I) induce similar immune responses to all of the antigens contained in V419 when given concomitantly with Prevnar13™ and RotaTeq™.","primaryOutcome":{"measure":"Geometric Mean Concentration of Antibodies to Polyribosylribitol Phosphate Antigen","timeFrame":"Postdose 3 (Month 7)","effectByArm":[{"arm":"V419 Lot A","deltaMin":5.51,"sd":null},{"arm":"V419 Lot B","deltaMin":6.1,"sd":null},{"arm":"V419 Lot C","deltaMin":6.59,"sd":null},{"arm":"Control","deltaMin":3.76,"sd":null},{"arm":"V419 Lots A, B, and C Combined","deltaMin":6.05,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG003 vs OG004","p":"<0.001"}]},"eligibility":{"minAge":"46 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["27846058"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":94,"n":2390},"commonTop":["Irritability","Injection-site pain","Crying","Somnolence","Decreased appetite"]}}